Nanocan Therapeutics Corporation Announces Appointments of Dr Elder Granger and Dr Paul Wallner to its Advisory Board
PRINCETON, New Jersey, 22 November 2021 / PRNewswire / – Nanocan Therapeutics Corporation today announced the appointment of Dr. Elder Granger, President and CEO of THE 5Ps, and Dr. Paul Wallner, Senior Vice President of Medical Affairs of Genesis Care United States, to its advisory board, in force 22 november, 2021.
“We are delighted to welcome Elder and Paul to the Nanocan Advisory Board. They come at an important time in the evolution of Nanocan and will be key additions going forward, ”said Eric Broyles, CEO of Nanocan. “As highly respected and accomplished individuals in their respective fields, their contribution to the commercialization of breakthrough therapies will be extremely valuable. ”
Paul wallner will succeed the former governor of Delaware Jack Markell who left Nanocan’s advisory board earlier this year. Governor Markell has been appointed by President Biden as the point of reference to oversee the relocation of Afghan evacuees to the United States. “We thank Governor Markell for his exemplary work on behalf of Nanocan and we wish him the best as he fulfills a vitally important mission on behalf of our country,” said Eric Broyles.
About Dr Elder Granger
Granger, 67, is currently President and CEO of THE 5Ps, a role he has held since 2009. Prior to his retirement from the US military the July 1, 2009, MG Granger was Deputy Director and Program Director of TRICARE Management Activity, Office of the Deputy Secretary of Defense (Health Affairs), Washington DC, of december 2005 To May 2009. In this role, he was the senior advisor to the Deputy Secretary of Defense (Health Affairs) on the policy and performance of the DOD health plan. Prior to joining the management activity of TRICARE, MG Granger led the largest U.S. and multinational battlefield healthcare system in our recent history, while serving as the Commander of Task Force 44th Medical Command and Surgeon command for the Multinational Iraq Corps. Granger graduated from Arkansas State University and doctor of medicine University of Arkansas Medicine School.
About dr. Paul wallner
Wallner, 79, is currently Senior Vice President of Medical Affairs at GenesisCare United States, Inc., United States division of an international cancer research and care organization. In this role, he is responsible for legislative and regulatory affairs, organizational relations, suppliers, medical schools and medical staff, compliance and quality assurance, research and education, as well as business development. In addition, he is also the Associate Executive Director of the American Board of Radiology, with responsibility for the initial certification and maintenance of certification of American radiation oncologists. Prior to joining GenesisCare, he was Professor and Chair of the Department of Radiation Oncology (DRO) at Robert Wood Johnson Medical School / Camden (NJ), Professor, Vice Chair of DRO, University of Pennsylvania Perelman School of Medicine and Head of the Clinical Radiation Oncology Branch of the National Cancer Institute. Wallner graduated with a bachelor’s degree from Saint Joseph University and a doctorate in osteopathic medicine from the Philadelphia College of Osteopathic Medicine.
About Nanocan Therapeutics Corporation
Nanocan Therapeutics Corporation is a clinical-stage biotechnology company developing cutting-edge nanotechnology-based innovations to treat cancers where current interventions are insufficient. Through its partnerships with leading academic research institutions, Nanocan aspires to create a new standard of care to help improve the lives of cancer patients. The company is also committed to making its disruptive innovations available to cancer patients in low- and middle-income countries, starting with Africa. https://www.nanocan.life
SOURCE Nanocan Therapeutics Corporation